Ουζμπεκιστάν: φαρμακευτικές φιλοδοξίες με επενδύσεις 1,2 δις € σε τοπική παραγωγή κι εξαγωγικό κόμβο

euronews (στα ελληνικά)

Ουζμπεκιστάν: φαρμακευτικές φιλοδοξίες με επενδύσεις 1,2 δις € σε τοπική παραγωγή κι εξαγωγικό κόμβο  Το Ουζμπεκιστάν αναβαθμίζει ταχέως τον φαρμακευτικό του τομέα με την έναρξη του Tashkent Pharma Park, ενός έργου ύψους 1,2 δισεκατομμυρίων ευρώ που ενώνει την έρευνα, την εφοδιαστική, την κατασκευή και την εκπαίδευση.   Σε συνεργασία με Agency of Information and Mass Communications of Uzbekistan  ΔΙΑΒΑΣΤΕ ΕΠΙΣΗΣ : http://gr.euronews.com/2025/06/24/oyzmpekistan-farmakeytikes-filodo3ies-me-ependyseis-12-dis-se-topikh-paragwgh-ki-e3agw  Γίνε συνδρομητής! ! Το euronews είναι διαθέσιμο σε 12 γλώσσες

Transcript

00:00Υπότιτλοι AUTHORWAVE

00:30This arm will be producing €440 million worth of pharmaceutical products a year by the end of 2025,

00:38with exports making up just over half that value.

00:42The new €1.2 billion Tashkent Pharma Park will drive further growth,

00:48while also creating 11,000 new jobs.

00:51Take a look at this.

00:52Spread over 1.9 million square metres,

01:02the Tashkent Pharma Park, when complete, is set to turbocharge the sector's expansion.

01:08A hub for distributing pharmaceutical products is already up and running.

01:13The products come from many countries, most of them from Europe,

01:19some of them from China and India and other countries,

01:22and we have around 60 to 70 million packs coming and going each month.

01:27Around 400 workers keep things moving here,

01:34with products distributed all over Uzbekistan.

01:38In the future, it's set to become an export hub for Central Asia, too.

01:43Within a few years, we plan to expand from $0 to $50 million of export.

01:48We have already signed a few contracts with a major place from Europe,

01:52and we are keen to see other players to come.

01:57Alongside logistics, the new Pharma Park will also have a centre for biotech and genome research,

02:04a technical university and manufacturing facilities,

02:08and all within a free economic zone, offering tax incentives.

02:14There will be huge integration of all the pillars of the industry,

02:17and that's the key.

02:19On top of that, we're also focusing on not only developing the local companies,

02:23but also we're trying to attract foreign investors.

02:26The reason is different methodology, different experience or different skills,

02:30and when you put all of them together, there will be a synergy.

02:35Established pharmaceutical companies are also driving up growth in the sector.

02:40This manufacturer is one of Uzbekistan's largest,

02:44making over 180 types of products.

02:47including tablets and ointments.

02:50It already exports to 11 countries.

02:54We want to expand our company to some other countries also,

02:59like Azerbaijan, some European countries, Turkey, and some African markets.

03:05We have experience, we have R&D centre, we know how to do it,

03:10so it's a good reason to expand the business and to supply the high-effective product in that market also.

03:17It's this kind of growth that Uzbekistan's looking to replicate,

03:22as part of its vision for the wider sector.

03:24By implementing international standards,

03:27we'll have more opportunity to go to European countries or America or other countries.

03:32This is where we're really right now working on.

03:35We also have to prove that we are strong in R&D sector,

03:38and we're also doing, as an example, clinical trials in Uzbekistan.

03:42All paving the way for this Central Asian country to claim its place on the global pharmaceutical map.

03:50Let's speak now to Oybek Shaikov from the Europe-Uzbekistan Association for Economic Cooperation,

04:00who's in Brussels.

04:01What do you think this all means for Europe, Ben?

04:04Of course, the deregulation of Uzbekistan's pharmaceutical sector,

04:09bringing to the WTO standards the production requirements as well,

04:13means that European companies have more opportunities to invest in Uzbekistan,

04:17especially for generic medicines, potential production,

04:21that ultimately might be able to expand into exports back to the European Union.

04:27But what about challenges, and how can they be navigated?

04:30Of course, the pharmaceutical sector is a very complex and very regulated sector.

04:34Ensuring high quality is extremely important,

04:37and I believe that the dialogue with the government that is taking place,

04:41also through Euros, is an extremely important element in that direction.

04:45Thank you very much indeed for your insights.

04:46Well, that's all we've got time for in this edition,

04:49but there's more business news at euronews.com.

04:52Thanks for watching, and bye for now.

Category

Transcript

Recommended